From: Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
Variables | Progression n (%) | Death n (%) |
---|---|---|
Overall (n = 28) | 4 (14.3) | 2 (7.1) |
Surgery (n = 19) | 2 (10.5) | 0 (0) |
No surgery (n = 9) | 2 (22.2) | 2 (22.2) |
Primary (n = 16) | 1 (6.3) | 0 (0) |
Surgery (n = 13) | 1 (7.7) | 0 (0) |
No Surgery (n = 3) | 0 (0) | 0 (0) |
Recurrent/metastatic (n = 12) | 3 (25.0) | 2 (16.7) |
Surgery (n = 6) | 1 (16.7) | 0 (0) |
No Surgery (n = 6) | 2 (33.3) | 2 (33.3) |